11 th Annual St. Vincents Cancer Care INDY HEMATOLOGY REVIEW 2014 State of Hematology: Reporting from ASH 2013 Ruemu E. Birhiray, MD Program Chair Partner,
Dr. Gopichand Pendurti M.B.B.S ACTIVITY OF RITUXIMAB AND OFATUMUMAB AGAINST MANTLE CELL LYMPHOMA(MCL) IN VITRO IN MCL CELL LINES BY COMPLEMENT DEPENDENT.
There are many ways to slice the “lymphoma pie”. Simplified classification of NHLs Indolent (low grade) Aggressive (intermediate grade) Highly aggressive.
Non Hodgkins Lymphoma M. Mahmood Khan, MD Hematology-Oncology 12/5/03.
There are many ways to slice the “ lymphoma pie ”
SPLENOMEGALY and LYMPHADENOPATHIES Hasan Atilla Özkan, MD. 1.
Current Standard of Care
